Solid Forms, Salts and Polymorphs of Anti-fibrotic Compounds
US-2024262785-A1 · Aug 8, 2024 · US
US9765017B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9765017-B2 |
| Application number | US-201415107962-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2014 |
| Priority date | Dec 27, 2013 |
| Publication date | Sep 19, 2017 |
| Grant date | Sep 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Allosteric hemoglobin (Hb) modifiers of hemoglobin which contain nitric oxide (NO) moieties allowing for the release of NO in vivo. The compounds retain the oxygen delivery capability of the allosteric hemoglobin modifier to bind Hb and enhance Hb's ability to deliver oxygen to cells and tissues, and also release NO from the NO moiety. Methods of delivering oxygen and/or NO to cells and tissues are also provided.
Opening claim text (preview).
We claim: 1. A compound having the general formula: wherein R1 and R2 are the same or different and are CH 3 , Cl, H, OCH 3 , or 5-carbon cyclic incorporating both R1 and R2; R3 is H, OH, COOH, or OC 2 H 5 ; R4 and R5 are the same or different and are H, CH 3 , cyclic incorporating both R4 and R5 and containing CH 3 substituents, OCH 3 , C 2 H 5 , phenyl, or unsubstituted phenyl; and R6 is a NO containing moiety selected from the group consisting of: 2. The compound of claim 1 having the formula: 3. A composition, comprising: one or more compounds as specified in claim 1 ; and a carrier. 4. The composition of claim 3 wherein said carrier is a liquid, and wherein said one or more compounds are dissolved or distributed in said liquid. 5. The composition of claim 4 wherein said liquid is an aqueous liquid. 6. The composition of claim 4 wherein said liquid is an oil. 7. The composition of claim 3 , wherein said carrier is a solid. 8. The composition of claim 3 wherein said carrier is a gas. 9. The composition of claim 8 wherein said gas is air.
Antimalarials · CPC title
Drugs for immunological or allergic disorders · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Antineoplastic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.